Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
and would be even higher today if the market hadn't caught a virus. I look forward to the divi here and more to come with FDA approval comes in. Really underrated share even at these levels and sure to benefit from the fallout from COV 29. Today's rise in profit is not to be sneezed at!
It is one of my core long term holdings - I just trade some around peaks and troughs. I added some in in Jan then sold some when it hit 440. After the trading update and the deteriorating outlook for Covid-19 this morning I have loaded up again for a longer hold as I think that a higher share values will stick this time.
IC kept their Buy rating, hardly surprisingly, but the was one comment at the end (below) about Chinese military and UK hospitals that was not in the trading statement. Not sure where this comes from - the investors meeting perhaps?
'Management has been careful not to paint the Aim-listed group as a play on the coronavirus, but suggested that the outbreak “will be a powerful influence on global healthcare systems for greater investment in infection prevention and control”. Nonetheless, fast-tracked orders from the Chinese military and stockpiling by UK hospitals suggest this year could see a swell in sales.'
I can see this going to at least 500 over the next few weeks (or less). Buying out the subsidiary in Italy looks to have been fortuitous.
The outbreak of Covid-19 in Tenerife is ominous; it is the end of the school holidays, many families will have been returning at the w/e, in addition everyone was congregated at the airports because of the canceled flights due to the sandstorm, ideal conditions for it to spread. I hope not but it is hard to see it not becoming pandemic.
wow - so it may hit 500 today.
Looks like the market is waking up to the Cov19 angle. Anything related to battling or preventing this virus currently will have no limits on the SP. Therefore though it would provoke a lot of profit-taking there is no reason 500p to 600p cant be attained in what is abnormal times
The Chinese order for surface cleaning disinfectant - apparently shipped last week and significant because it required a special exemption as the Chinese regulators have yet to formally approve this product - was mentioned at the investor briefing last night, as was increased ordering by NHS hospitals. The Chinese order was also mentioned in the lead article this morning in The Times Business section (Market report) "Virus provides opportunity for Tristel to clean up", picking up on briefings to the analysts. Unusual for such a small company to hit the headlines.
There are multiple opportunities for this company to grow much further, quite aside from the current focus relating to the Covid-19 virus. I think that we are still in the foothills.
Thanks for confirming the source of the information James. I prefer it when companies have a webinar of the investor meetings as there is often extra information beyond that just in the slides, not least often the answers to questions from the people present.
I agree that this has a way to go outside of covid-19 although this is clearly what is driving the price up now. Beyond immediate sales this will also help to drive longer term sales growth as it increases product awareness.
Yes; I agree that webinars are very useful, but they tend to be the preserve of the larger listed companies, rather than fairly small companies on AIM.It may be down to cost. The only small AIM co I know that does this sort of thing (there may be others) is Judges Scientific (JDG) in relation to their briefing to analysts. TSTL is much more user friendly than most - morning and evening briefing sessions for shareholders of interim and final results, plus a well attended shareholder day at their Snailwell HQ each July. On top of that, Finncap (house broker) is one of the few brokers who give wide access to their briefing notes, the latest of which came out yesterday.